Characterizing insulin dosing behaviour and glycaemic excursions: Development of metrics using connected insulin pen and continuous glucose monitoring

被引:0
|
作者
Wolpert, Howard [1 ]
Rodbard, David [2 ]
Xue, Jie [3 ]
Johnson, Jennal [3 ]
Dassau, Eyal [3 ]
机构
[1] Boston Med Ctr, Boston, MA USA
[2] Biomed Informat Consultants LLC, Potomac, MD USA
[3] Eli Lilly & Co, Indianapolis, IN USA
关键词
continuous glucose monitoring (CGM); glycaemic control; hypoglycaemia; insulin therapy; observational study; INTERNATIONAL CONSENSUS;
D O I
10.1111/dom.16249
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: Connected insulin pens (CIPs) provide insulin dosing data that can be leveraged to drive improvements in glycaemic control. To realize this potential in routine care, insulin data need to be distilled into actionable insights for clinicians. We describe two algorithms for detecting glucose excursions using continuous glucose monitoring (CGM) data and then link excursions to CIP data to derive "insulin metrics" characterizing suboptimal bolus dosing practices. Materials and Methods: This post hoc analysis used CGM and CIP data from a 12-week observational study (: NCT03368807) of 64 adults with type 1 or type 2 diabetes receiving multiple daily injection insulin therapy and glycated haemoglobin >= 8%. Two updated algorithms were applied to analyse glucose excursions associated with pre-meal boluses, missed bolus doses (MBDs), delayed boluses and correction boluses. Results: Glycaemic metrics obtained using both algorithms were similar. Time in range (%TIR) was lower, and time above range (%TAR) and glycaemic variability (%GV) were higher, on days with MBDs. Compared with pre-meal boluses, delayed and correction boluses were followed by glucose excursions with larger change in glucose, longer duration with glucose >180 mg/dL, lower post-excursion %TIR and higher post-excursion %TAR; excursions following MBDs showed lower %TIR, higher %TAR and lower percent recovery. Glucose excursions were larger and longer when CGM was masked than when unmasked. Conclusions: This analysis demonstrates "insulin metrics"-characterizations of insulin dosing behaviour derived from integrated CGM and CIP data-and provides a foundation for future work that will expand the understanding of an individual's insulin self-administration practices and improve clinical decision-making.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Comparing Equil patch versus traditional catheter insulin pump in type 2 diabetes using continuous glucose monitoring metrics and profiles
    Li, Yu-Jiao
    Shao, Zi-Yue
    Zhu, Yun-Qing
    Chen, Da-Shuang
    Zhu, Jian
    JOURNAL OF DIABETES, 2024, 16 (04)
  • [42] Evaluation of safety of insulin degludec on undergoing total colonoscopy using continuous glucose monitoring
    Takeishi, Soichi
    Mori, Akihiro
    Fushimi, Nobutoshi
    Hachiya, Hiroki
    Yumura, Takayuki
    Ito, Shun
    Shibuya, Takashi
    Ohashi, Noritsugu
    Kawai, Hiromi
    JOURNAL OF DIABETES INVESTIGATION, 2016, 7 (03): : 374 - 380
  • [43] Effects of Insulin Degludec in Patients with Diabetes Using Continuous Glucose Monitoring: A Scoping Review
    Wang, Chaofan
    Xu, Wen
    Yang, Xubin
    Yan, Jinhua
    Yang, Daizhi
    Yao, Bin
    Weng, Jianping
    DIABETES, 2021, 70
  • [44] Evaluation of Glucose Response to 3 Types of Insulin Using a Continuous Glucose Monitoring System in Healthy Alpacas
    Byers, S. R.
    Beemer, O. M.
    Lear, A. S.
    Callan, R. J.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2014, 28 (05) : 1613 - 1620
  • [45] Glucose excursions detected by the continuous glucose monitoring system and missed by routine self-monitoring blood glucose measurements in patients with type 1 and type 2 diabetes requiring insulin
    Lee, SW
    Freitas, M
    Petrofsky, J
    Chao, E
    Gomez, L
    Im, R
    Magbual, R
    DIABETES, 2004, 53 : A105 - A105
  • [46] Effects of Pioglitazone and Insulin on Tight Glycaemic Control Assessed by the Continuous Glucose Monitoring SystemA Monocentric, Parallel-Cohort Study
    Wolfgang Jung
    Sigrun Jung
    Clinical Drug Investigation, 2005, 25 : 347 - 352
  • [47] Effects of pioglitazone and insulin on tight glycaemic control assessed by the continuous glucose monitoring system - A monocentric, parallel-cohort study
    Jung, WG
    Jung, SR
    CLINICAL DRUG INVESTIGATION, 2005, 25 (05) : 347 - 352
  • [48] Continuous glucose monitoring for glycaemic control and cardiovascular risk reduction in patients with type 2 diabetes not on insulin therapy: A clinical trial
    Reed, Joseph
    Dong, Tony
    Eaton, Elke
    Friswold, Janice
    Porges, Jodie
    Al-Kindi, Sadeer G.
    Rajagopalan, Sanjay
    Neeland, Ian J.
    DIABETES OBESITY & METABOLISM, 2024, 26 (07): : 2881 - 2889
  • [49] Towards the Development of an Artificial Pancreas: Continuous Glucose Monitoring and Closed-Loop Insulin Delivery
    Tamborlane, William
    HORMONE RESEARCH, 2008, 70 : 8 - 8
  • [50] Hypoglycaemic Episodes and Glycaemic Variability in Ealy Stage Type 2 Diabetes Patients Treated With Monotherapy Insulin Glargine and Metformin, Using Continuous Glucose Monitoring
    Koehler, Carsta
    Schaper, Frank
    Pistrosch, Frank
    Henkel, Elena
    Hoffmann, Caren
    Steiner, Juliane
    Staudte, Ronny
    Landgraf, Wolfgang
    Bilz, Susanne
    Schoner, Constanze
    Hanefeld, Markolf
    DIABETES, 2013, 62 : A227 - A227